Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8729 |
High Similarity |
NPD228 |
Approved |
0.8571 |
High Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.845 |
Intermediate Similarity |
NPD9494 |
Approved |
0.8261 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.8261 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.812 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.8085 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8074 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.806 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.806 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.8045 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8016 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD826 |
Approved |
0.8 |
Intermediate Similarity |
NPD825 |
Approved |
0.8 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7984 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7953 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7941 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7941 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7934 |
Intermediate Similarity |
NPD1358 |
Approved |
0.791 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7891 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7883 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7872 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7869 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7846 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7829 |
Intermediate Similarity |
NPD1778 |
Approved |
0.782 |
Intermediate Similarity |
NPD5647 |
Approved |
0.781 |
Intermediate Similarity |
NPD555 |
Phase 2 |
0.7803 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7786 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7769 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7769 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.776 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7748 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7721 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7717 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7714 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.771 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7705 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7692 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7687 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7687 |
Intermediate Similarity |
NPD258 |
Approved |
0.7687 |
Intermediate Similarity |
NPD257 |
Approved |
0.7674 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7664 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7664 |
Intermediate Similarity |
NPD259 |
Phase 1 |
0.7661 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7661 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7655 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7655 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7652 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7651 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7616 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7616 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7615 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7615 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7609 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7609 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7589 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7589 |
Intermediate Similarity |
NPD2239 |
Approved |
0.7589 |
Intermediate Similarity |
NPD2240 |
Approved |
0.7576 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7574 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7559 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7535 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7533 |
Intermediate Similarity |
NPD37 |
Approved |
0.75 |
Intermediate Similarity |
NPD3687 |
Approved |
0.75 |
Intermediate Similarity |
NPD2653 |
Approved |
0.75 |
Intermediate Similarity |
NPD9569 |
Approved |
0.75 |
Intermediate Similarity |
NPD3686 |
Approved |
0.75 |
Intermediate Similarity |
NPD4966 |
Approved |
0.75 |
Intermediate Similarity |
NPD4965 |
Approved |
0.75 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7482 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7481 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7481 |
Intermediate Similarity |
NPD1651 |
Approved |
0.748 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7464 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7464 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7458 |
Intermediate Similarity |
NPD9296 |
Approved |
0.745 |
Intermediate Similarity |
NPD3111 |
Phase 1 |
0.7445 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7424 |
Intermediate Similarity |
NPD17 |
Approved |
0.7419 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7388 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7383 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7372 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD454 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1006 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD290 |
Approved |
0.7357 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7353 |
Intermediate Similarity |
NPD987 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7343 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7343 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7343 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7343 |
Intermediate Similarity |
NPD1501 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7338 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4359 |
Approved |
0.7325 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7315 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7305 |
Intermediate Similarity |
NPD274 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7305 |
Intermediate Similarity |
NPD275 |
Approved |
0.7286 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7285 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD196 |
Phase 1 |
0.7278 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7266 |
Intermediate Similarity |
NPD9536 |
Phase 1 |
0.7266 |
Intermediate Similarity |
NPD9537 |
Phase 1 |
0.7261 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7259 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7252 |
Intermediate Similarity |
NPD9493 |
Approved |
0.725 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7248 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7236 |
Intermediate Similarity |
NPD291 |
Approved |
0.7234 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7231 |
Intermediate Similarity |
NPD2629 |
Approved |
0.723 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7226 |
Intermediate Similarity |
NPD6362 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7222 |
Intermediate Similarity |
NPD9570 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7219 |
Intermediate Similarity |
NPD824 |
Approved |
0.7214 |
Intermediate Similarity |
NPD411 |
Approved |
0.7209 |
Intermediate Similarity |
NPD821 |
Approved |
0.7206 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7206 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7206 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7205 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7194 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD2976 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7188 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7185 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7183 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7172 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7172 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7172 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7172 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7172 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7153 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD2370 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD5163 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD968 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7132 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD6873 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD7596 |
Clinical (unspecified phase) |
0.7122 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD3866 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD690 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7092 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7091 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD2821 |
Approved |
0.7075 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7075 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7075 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7067
|
Intermediate Similarity |
NPD2534 |
Approved |